Medical Properties Trust Inc (MPT) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
Medical Properties Trust Inc   (NYSE: MPT)

Select the Financial Report: Select the Period:


Description of Medical Properties Trust Inc's Business Segments





Composition of Medical Properties Trust Inc Revenues by Segments

 
US    56.67 % of total Revenue
GB    38.06 % of total Revenue
All Other Countries    8.13 % of total Revenue

Q1 three months ended (Mar 31 2026)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
Total 252.07 100 %
US 142.85 56.67 %
GB 95.94 38.06 %
All Other Countries 20.49 8.13 %




Q1 three months ended (Mar 31 2026)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
Total - -74.07 %
US - -
GB - -
All Other Countries - -




Q1 three months ended (Mar 31 2026)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Total 33.11 13.13 %




Q1 three months ended (Mar 31 2026)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Total - -




Annual Report on Medical Properties Trust Inc Divisions, Sales by Country

 


Twelve months ended 2025
MPT s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
Total 972.02 100 %


Twelve months ended 2025
MPT s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Total -275.94 -

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.